University status and response to COVID-19
Please click on the link below for the latest health information:
https://www.ox.ac.uk/coronavirus/health
Podcast: Meet our researchers
LATEST NEWS
Trial investigating potential treatment for fatigue relief in people with long COVID reports results
17 April 2023
Researchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue. The study (reported in Lancet eClinical Medicine) found participants given the treatment, developed by US pharmaceutical company Axcella Therapeutics, reported feeling less fatigued than those given a placebo.
R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana
14 April 2023
The University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax’s adjuvant technology, has been licensed for use in Ghana by the country’s Food and Drugs Authority.
Events
Recent publications
-
Deep Proteomics Network and Machine Learning Analysis of Human Cerebrospinal Fluid in Japanese Encephalitis Virus Infection.
Journal article
Bharucha T. et al, (2023), J Proteome Res
-
An enrichment protocol and analysis pipeline for long read sequencing of the hepatitis B virus transcriptome
Journal article
Ng E. et al, (2023), Journal of General Virology, 104
-
DEcancer: Machine learning framework tailored to liquid biopsy based cancer detection and biomarker signature selection
Journal article
Halner A. et al, (2023), iScience, 26, 106610 - 106610
-
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity.
Journal article
Wing PAC. et al, (2023), PLoS pathogens, 19
-
Tau filaments are tethered within brain extracellular vesicles in Alzheimer's disease.
Journal article
Fowler SL. et al, (2023), bioRxiv
-
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination.
Journal article
Yin Z. et al, (2023), Cell Rep, 42